Keywords: merck, kgaa, invests, developing, its, cancer, treatment

Merck KGaA invests in developing its cancer treatment Erbitux

Article | 28 March 2005

Print This

German pharmaceutical firm Merck KGaA has outlined plans to step up an ambitious clinical trial program for its leading cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in